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Objective: Pain is the most common symptom and reason for why affected individuals 
seek out medical attention for injuries.  The most common pain scales are: the 
numerical rating scale (NRS), 5-point verbal rating scale (VRS-5), and visual analog scale 
(VAS) but there is no gold standard established to measure unidimensional pain 
intensity. Algometry is an objective technique to measure pain pressure threshold and 
tolerances.  However, there is little research on which scale is best suited to assess pain 
intensity in different demographics; including athletic populations and other types of 
groups; as well as, whether subjective pain scale measurements can be correlated to 
objective algometric measurements.  
Methods: Both men and women between the ages of 18-35 with joint pain were 
recruited to participate in the study. The four common pain scales (NRS, VAS, VRS-5 
Mankoski) as well as patient specific functional scale(PSFS), brief resiliency scale(BRS), 
and pain catastrophizing scale (PCS) were completed by each subject.  Then each 
participant had their pressure discomfort threshold (PDT) and pressure pain tolerance 
(PPT) tested with an algometer at 3 pre-determined sites as well as where the subject 
had joint pain, bilaterally. Data was analyzed and sorted into subgroups: National 
Collegiate Athletic Association (NCAA) Division I athletes and non-collegiate athletes, 
men and women, injured and non-injured. 
Results: Participants (n=69) completed the study, all of the pain scales were consistently 
correlated together in every subgroup of data (collegiate athlete vs non-collegiate 
athlete, men and women, injury status). The pain scales were not consistently 
iv 
correlated to any of the algometric measurements.  Collegiate athletes rated their pain 
higher than non-collegiate athletes using the NRS.  There were no statistically significant 
differences between genders, but men consistently tolerated more force when applied 
during algometry measurements.  The individuals, who identified as injured, had higher 
pain ratings on pain scales but tolerated a similar amount of force applied when the 
algometry measurements were taken. 
Conclusion: NRS, VAS, VRS-5, Mankoski scales could all be used to assess the pain 
intensity of athletes or the athletic population.  Clinicians should be aware that NCAA 
Division I collegiate athletes have higher pain thresholds and pain tolerances compared 
to non-collegiate athletes. 
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Pain is a part of life, experienced by all, and is one of the most common patient 
complaints in healthcare and has been studied in the medical field for hundreds of 
years1-6.  However, pain perception is complex with various neurological processes and 
can be significantly impacted by a multitude of different factors7-11.  Pain is also 
subjective, varying greatly among individuals.  While there has been extensive 
research into pain and pain assessment, there is no specific gold standard of how to 
assess unidimensional pain intensity10,12-17.  Each self-rated pain scale subjectively 
assesses pain intensity differently and consequently has differing advantages and 
disadvantages18-20  The most common pain scales utilized for self-reported pain 
intensity are the: numerical rating scale (NRS), verbal description scale (VDS), and 
visual analog scale (VAS)18,21-26.  All of those pain scales have been well investigated 
regarding efficacy of use with the general population and in some sub-populations 
such as chronic pain patients18,19,24-28.  A sub-population that has not been thoroughly 
investigated is the active population including both competitive athletes and 
recreationally active individuals.  There is a consensus within the literature that people 
within the active population, like athletes, have higher pain thresholds and pain 
tolerances29.  However, there is little pain scale research regarding which scale is best 
suited for assessing pain intensity in athletic or active populations.   
 Due to the inherent flaws with subjective assessments of pain, the most 
notable being the variation in perception between individuals, attempts at objectively 
quantifying pain ratings have been made14,30-34.  A potential objective technique to 
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measure pain is with the use of an algometer, a device that measures the amount of 
force needed to reach an individual’s pain pressure threshold.  The current literature 
demonstrates that the use of algometers in clinical settings is quite feasible due to low 
cost and minimal training required to complete algometric measurements35-40. 
Previous studies have also indicated valid and reliable measures when using multiple 
different anatomical sites35,37,38,41,42.  Additionally, algometric measures have been 
demonstrated to have high test-retest reliability30,35,38,39,41,43-45.  In studies performed 
by van Wilgan et al and Kregel et al, an algometer was used to assess the progress of a 
pathology or current treatment plan being implemented30,35,38,39,41,43-45.  However, 
there have yet to be studies that correlate algometry measurements with any pain 
scale ratings.  It is possible that algometry measurements could be used to objectively 
quantify pain (and relate them to pain scale measurements) by obtaining a baseline 
measurement and then comparing the baseline value to post-injury values taken 
immediately after injury and for the duration of treatment of said injury. This process 
would clinically verify if self-reported pain perception provided by the patient relates 
to the objective pain pressure threshold thus providing clinicians a more robust 
understanding of individual patient pain perception and possible coping. 
 Although it has been reported that athletes have higher pain tolerances and 
pain modulation capabilities, it is unknown if the commonly used pain scales that have 
been studied within general population and chronic pain populations are similarly 
effective/accurate for athletic populations.  Therefore, the purposes of this study were 
to determine if the pain scales used for the general population could be specific and 
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sensitive to the athletic population and if algometry measurements could be used to 
quantify pain.  The hypothesis was that all pain ratings would be positively correlated 
to each other and the algometry measurements.  The second hypothesis was that 
there would be overall higher pain thresholds and tolerances seen with the athletic 
population compared to non-athletic population. 
There were several potential limitations and delimitations to the study.  Since 
recruitment and data collection was completed on a college campus, the majority of 
participants were between the ages of 18 and 25.  With data being collected on a 
smaller age range, there was a potential decrease of generalizability to older age 
groups from any correlations found.  Since the study was partially survey-based, there 
was the possibility that subjects would not complete the survey truthfully, potentially 
skewing the data collected on pain scale measurements.  By using the algometers, 
inter-rater and intra-rater reliability must be established if more than one clinician 
completes algometric data collection. 
For this experimental design, the assumption was that athletes or people who 
are more physically active on a regular basis are going to have higher pain pressure 
threshold levels and tolerances.  The differences between active and sedentary 
population thresholds and tolerance levels have been previously observed in 
literature29,46.  The differences observed could be potentially due to active populations 
being in pain more frequently thus learning to cope with the sensation47.  People who 
are physically active are more likely to have a musculoskeletal injury compared to 
sedentary populations due to increased exposures to high demands and loads on their 
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bodies.  Additionally, the mentality of ‘no pain, no gain’ is common within the athletic 
population and they are more likely required to tolerate pain from physical activity like 
muscle soreness while continuing to maintain activities of daily living12,47. 
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 Definition of Terms 
• Action potential - the nerve’s capability to send an electrical signal 
• A-delta fibers - small-diameter, highly myelinated fibers that quickly transmit 
stimuli information, like: mechanical pressure, extreme temperatures, and 
ischemic pain. When activated, individuals can feel sharp pain, usually seen with 
acute injuries 
• Algometer - device that measures the intensity of applied pressure (N) required to 
elicit pain at pain threshold and pain tolerance levels 
• C-fibers - small diameter, unmyelinated that are stimulated by mechanical pain, 
extreme temperatures, and chemicals. When activated, individuals can feel 
nonlocalized, dull, diffused pain 
• Exercise induced hypoalgesia (EIH) – a marked decrease in sensation seen in 
individuals exercising, potentially due to the release of endogenous chemicals 
• Neural signature – also known as neurotag or neuromatrix, is the sequence of brain 
structures that receive nociceptive signals and are part of the determining if stimuli 
is painful 
• Nociception - neural processes of receiving noxious stimuli picked up by receptors 
throughout the body and then sending a signal regarding the stimuli collected to 
the brain for interpretation 
• Pain threshold - the level reached when an individual begins to feel pain 
• Pain tolerance - the highest level of pain tolerable by the individual 
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Significance of the Study 
There has yet to be a study that examines how effective commonly used pain scales 
with the general population are for active and athletic populations.  Additionally, 
research has yet to be conducted to determine if there is a relationship between pain 
pressure threshold measurements and self-reported pain levels and/or sensations. It is 
possible that quantification of pain in the clinical setting may provide further 






Nociception is the neural processes of receiving noxious stimuli picked up by 
receptors throughout the body and then sending a signal regarding the stimuli 
collected to the brain for interpretation7. The interpretation of stimuli is a process that 
can be broken down into three parts – alert, message, and response7.  There are a 
multitude of different types of nerve receptors throughout the body which respond 
and activate to different stimuli.  Every receptor is attached to a corresponding nerve. 
An alert is any kind of stimuli that is picked up by receptors and so triggers a normal 
neural response.  When the nerves become activated by the stimulated receptors, an 
action potential (the nerve’s capability to send an electrical signal) is generated and 
fired, which carries the alert along the nervous system to the brain as a message. A-
delta and C fibers are the afferent (sensory) nerve fibers that transmit signals to the 
dorsal horn of the spinal cord which gets further relayed to the cerebral cortex.   From 
the cerebral cortex, the message is analyzed and interpreted as either painful or non-
painful stimuli. If it is classified as painful, the brain then determines if the body is 
either in danger or not, which dictates the type of response to the potentially painful 
stimuli7.  
A-delta fibers are small-diameter, highly myelinated fibers that quickly transmit 
stimuli information, like mechanical pressure, extreme temperatures, and ischemic 
pain7.  When A-delta fibers are activated, the response the individual feels is a sharp 
pain, as seen with acute injuries7.  C fibers are small diameter, unmyelinated fibers 
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that are stimulated by mechanical pain, extreme temperatures, and chemicals.  C 
fibers are the most abundant type of nerve fiber in the body and their purpose is to 
monitor the body for potential problems which is why it can be activated by many 
different types of stimuli7.  Different chemicals produced by the body either routinely 
or in response to stimulation can cause different effects on C fibers.  Bradykinins and 
histamines directly stimulate C fibers while prostaglandin increases the sensitization of 
nerve fibers and increases the nociceptive impact of other mediators.  Substance P is a 
neurotransmitter that produces pain response, peripherally produces hyperalgesia, 
and inflammatory responses7.  When C fibers are activated from stimuli, the individual 
may feel the response of nonlocalized, dull, diffused pain7. 
For the nociceptive signal to be sent from the activated A-delta fibers or C fibers, 
the level of noxious stimulus must be strong enough to reach the individual’s pain 
threshold which when reached generates and fires an action potential7.  Once the 
stimulus reaches the pain threshold, the message is sent through the dorsal horn of 
the spinal cord, past the interneuron block and is then passed along to the cerebral 
cortex via second order neurons. The nociceptive signal is received and bounced to 
several different parts of the brain where it is interpreted then as pain3.  The different 
order of which parts of the brain receive and send the nociceptive signal creates a 
neural signature, sometimes referred to as pain neurotag, neuromatrix, or map3.  It is 
postulated that this so-called matrix exists in order for the brain to quickly determine if 
the signal from the stimulus poses a danger to the individual possibly leading to harm 
(physical and/or psychological).  If the individual’s perception is that danger is present, 
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and harm may occur, then their fight or flight response may occur.  The fight or flight 
response causes the release of epinephrine to allow the individual to escape or defend 
from the painful stimulus.  The brain could also determine that there is not a threat or 
danger and release endogenous, inhibitory chemicals to modulate the nociceptive 
signal being sent from the activated A-delta and C fibers3.  Conversely, there are a 
variety of different endogenous inhibitory chemicals produced by the body used to 
decrease pain perception including opioids, enkephalins, endorphins, and serotonin3.  
In chronic pain patients, it has been observed that their nerves become more 
sensitized and have an increased excitability resting rate (or a decreased threshold) 
which results in the need of less stimuli to reach the same pain threshold to fire an 
action potential.  In other words, it takes a much smaller amount of stimulation for a 
person in chronic pain to perceive a stimulus as potentially or actually harmful 
compared to an individual without pain.  The increased rate of nociceptive signals 
activating A-delta and C fibers results in a faster and more sensitive neural signature 
and a decreased pain modulation ability3, thus creating more perceived pain 
sensations for the individual.   
With more active populations, there is an increased risk for musculoskeletal injury 
during activity. Active people are more likely to endure pain from injuries with 
differing significance but have a very different pain perception than in chronic pain 
patients.  In the athletic population, the difference could potentially be explained due 
to a different type of neural signature formed where the brain does not perceive the 
nociceptive signals as pain and releases nociceptive-inhibition chemicals earlier as a 
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result of an adaptation to consistent exercise.  The release of such endogenous, 
inhibitory chemicals is associated with exercise-induced hypoalgesia (EIH) and 
attributed to how athletes can keep performing after being seriously injured29.  
However, the concept of EIH is not fully understood and needs additional research.   
With some studies, there has also been significant increased pain tolerance and pain 
threshold levels within athletic populations when compared to normal active 
controls29.  The differences in pain tolerance and threshold signify how the athletic 
population differs from general population and so may change the efficacy of how 
clinicians measure and assess pain with active populations. 
Pain Scales 
Pain is the most common complaint clinicians hear about and has been 
referred to as an additional vital sign7.  Although pain is the most common patient-
reported symptom, assessing pain has not been completely standardized.  Currently, 
there are many different unidimensional pain scales that measure pain intensity 
including the Visual Analog Scale (VAS), Numerical Rating Scale (NRS), Verbal Rating 
Scale (VRS)/ Verbal Description Scale (VDS), or FACES Pain Rating Scale22.  While all 
unidimensional pain scales measure pain intensity, each pain scale is different and 
assesses pain intensity differently.     
The VAS is a 10 cm line anchored with “no pain” and the opposite end being 
“worst possible pain”.  The VAS is a seemingly straightforward pain scale to administer. 
However, in several studies, elderly and disadvantaged populations have difficulty 
accurately completing the scale22,26.  Another obstacle with utilizing the VAS is that 
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clinician must measure and determine the score of the pain scale based on the 
patient’s feedback18.  Results can also be impacted by the visual orientation of the pain 
scale being vertical or horizontal22.  
The NRS can be utilized for rating an individual’s pain level from a scale of zero 
to ten or zero to 100, with zero being “no pain” and the other anchor being at level 10 
or level 100 being “worst pain possible”.  In a systematic review by Hjermstad et al., 
NRS had better patient compliance in multiple different sub-populations when 
compared with VAS and VRS22.  Data from NRS has also been shown to be more easily 
analyzed for audit purposes7.  While the scale is easily implementable, it has been 
found in the Douglas study that patients have difficulty assigning a number to describe 
their pain without some form of reference from past experience28.  
The VRS or VDS is an ordinal list of descriptive words that go from least to 
greatest severity.  For example, in a 4-point VRS the words could be: no pain, some 
pain, considerable pain, and pain which could not be more severe.  In another form of 
VRS, the 5-point version or VRS-5, the words can be: mild, discomforting, distressing, 
horrible, excruciating18.  Another scale, very similar to the VRS is the FACES pain scale 
(FPS)7.  The FACES pain scale is an image of several faces, from smiling to saddening or 
with more pain being portrayed22.  The FPS has been suggested to use for acute pain in 
the pediatric population due to its ease of use and ease of comprehension with the 
younger population7.  The scale has also been found to be easily translated into 
different languages and still be a valid measurement of pain intensity48.  Each face is 
paired with a number 0-10, ascending even numbers.  Each face having a 
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corresponding number allows for ease of use in a research context. However, since the 
scale goes up by even numbers, it could be interpreted to have decreased sensitivity 
when compared to other scales, like the NRS. 
Since there are various tools to assess pain, studies have been completed 
comparing the feasibility, advantages, and disadvantages of each pain scale.  
Williamson and Hoggart, established that VAS, VRS, and NRS were reliable, valid, and 
practical to use. VAS had some practical difficulties the other pain scales assessed did 
not49.  From analysis in multiple studies, a good correlation has been established 
between VAS, VRS/VDS, and NRS22.  Jensen et al. also found that VAS and NRS were 
more sensitive to change and could be better to implement when measuring pain with 
the same patient repeatedly over the course of a longer treatment period18.  By being 
aware of specific limitations of different pain scales, clinicians can choose which pain 
scale to utilize that is best suited pain scale in context to their specific practice. 
Another pain scale that addresses some of the obstacles of other pain scales is 
the Mankoski scale.  The Mankoski scale, developed by Andrea Mankoski, was 
originally developed to assess pain in endometriosis patients28.  The pain scale is 
similar to NRS with each number associated with a descriptive phrase, like VRS/ VDS.  
The Mankoski scale was assessed as reliable and valid while being compared to VAS, 
NRS, and Faces pain scale.  Additionally, within the population of veterans with 
chronic, it was the most preferred pain scale to use when describing pain28.   However, 
there is a lack of research on the Mankoski scale since it has not been extensively 
studied. 
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Within systematic reviews, Tesarz et al. and Karcioglu et al., assessed the level 
of bias from the literature collected22,29.  Tesarz et al. assessed studies and found levels 
of bias as high in four studies, moderate in eight studies, and no articles with low levels 
of bias29.  In other words, all current articles identified by Tesarz et al.’s study have 
moderate to high levels of bias which demonstrates that the current literature and 
clinical applications are limited29.  Karcioglu et al., categorized studies as high, low, and 
unclear levels of bias with eight, seven, and four studies falling into each category 
respectfully22.  Karcioglu et al., assessed quality of evidence in grades of A through D, 
with twelve studies within grade B and seven studies within grade C22.  Articles with 
higher level of bias or low grade of quality means that there is low generalizability of 
the conclusions gathered from the study.  Therefore, the lack of low bias and high-
grade quality evidence demonstrates the need to continue research in the efficacy of 
how clinicians assess pain and with what tools. 
Algometry 
There have been multiple studies that examine pain threshold and pain tolerance 
with various methodologies.  Pain threshold (the level reached when an individual 
begins to feel pain) and pain tolerance (the highest level of pain tolerable by the 
individual) have been quantitatively measured by cold water, mechanical pressure, 
ischemic methods, electrical and heat7,29. These measurements are often obtained via 
devices used in comparative studies and in most cases require expensive, complicated 
equipment.  A more clinically applicable and inexpensive technique to measure pain 
threshold and pain tolerance is through the use of an algometer, which is a device that 
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measures the intensity of applied pressure required to elicit pain.  By applying 
pressure, the clinician can determine when pressure is first notes as pain (threshold) 
and when it is no longer tolerated (maximum tolerance level).  The ability to quantify 
pain levels is significantly helpful in the diagnosis and treatment of pain syndromes 
and other diagnoses43,50.  
There are different ways to incorporate algometric measurements into 
assessments and diagnoses.  Majority of studies completed algometry measurements 
by testing a pathologic or predetermined specific site multiple times within a set time 
period in between trials. This method is classified as the cluster protocol35,37,39,42,43,45.  
A different protocol identified by Bisset, Evans, and Tuttle is the circuit protocol which 
one site is tested and then moved on to the next site until all sites have been 
measured.  Afterwards, the test sites were revisited in the same order until the 
number of measurements desired at each location has been obtained – thus a circuit35.   
Among the different ways to test pain pressure threshold, there have been a 
multitude of different test sites used to measure pain pressure threshold with an 
algometer.  Some more commonly tested sites are the dorsal aspect of the wrist at the 
midline of the joint, the muscle belly of the tibialis anterior, the trapezius muscle 
between the spinous process on the seventh cervical vertebrae and lateral acromion, 
and the erector spinae – about 2 cm lateral of the fourth and fifth lumbar vertebrae 
junction35,38,45.  The reason for the chosen anatomical sites could be that the sites are 
already sensitive areas that consist of bony and soft tissue areas.  Additionally, 
Charleston et al. chose contralateral anatomical sites that corresponding to 
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pathological tender spots or ‘hot spots’36.  Fryer, Morris, and Gibbons research 
demonstrated that one can use the algometer to measure pain pressure threshold in 
deep muscles, specifically deep, medial paraspinal regions.  The ability to reach and 
measure pain pressure threshold in deep muscles increases the potential application 
of algometers in clinical settings45. 
There are also different algometry tools to measure pain pressure threshold. Koo, 
Guo, and Brown found that using a manual, hand-held algometer device rather than a 
computerized algometer led to higher rates of test-retest reliability, repeatability, and 
sensitivity37.  Several studies also found similar results of high inter-rater and intra-
rater reliability using manual algometers35,38,42,43.  Due to high levels of inter-rater and 
intra-rater reliability being identified by multiple investigators, it is evident that 
algometry can be employed in the clinical setting by both novice and experienced 
clinicians.  Additionally, the multiple high reliability ratings also demonstrate the ability 
to use an algometer to measure pressure threshold measurements consistently and so 
the application of findings is possible. 
Some studies indicate the reliability and feasibility of the use of algometry and pain 
pressure threshold and use as a diagnostic tool. Kregel et al. and Wilgen et al. used a 
handheld algometry device to diagnose patellar tendinopathy to aid with the diagnosis 
of patellar tendinopathy along with manual pressure and the Victorian Institute of 
Sports Assessment – Patellar (VISA-P) questionnaire within collegiate student 
athletes39,43.  The use of algometers was also considered to evaluate the progression 
and impact of rehabilitation of patellar tendinopathy39.  Kregel et al. specifically stated 
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that the use of an algometer had “…excellent sensitivity and specificity, and equivalent 
positive predictive value”43 (Kregel et al, 2013, p 1773).  Frank, McLaughlin, and 
Vaughan found that pain pressure threshold measurements on spinal segments were 
statistically stable with consecutive days of testing and same day testing42.  Results 
from Frank et al. study demonstrate that algometer devices can be used as a 
repeatable measure for pain pressure threshold in patients with pain syndromes or 
diagnoses like low back pain as well as used to measure changes in pain experienced 
repeatedly42.  The use of algometry is an appropriate method to quantify patients’ pain 
levels in clinical settings and can be used repeatedly to provide quantified data 
regarding patients’ pain levels over an extended period of time. 
From the studies previously published, there is significant consensus that more 
future studies need to occur with larger sample sizes and investigate pain pressure 
threshold in different specialized populations.  Additionally, larger sample sizes are 
needed for data analysis to include separate measurements via gender to determine if 
there is a gender influence on pain pressure threshold measured by algometer38.   
Studies that examined general population found that men tolerated more force 
applied in a various of sites compared to women38,41.  Kregel et al, also found that 
healthy male and female athletes tolerated the similar amounts of force applied during 
algometry measurements (male athletes PPT 50.3±5.1, female athletes PPT 
49.9±5.0)43.  There is significant potential to use such a tool for the diagnosis of some 




Pain is the most common complaint that clinicians hear and is often the reason 
why people seek medical treatment.  There have been studies that investigated the 
reliability and validity of different pain scales for general population. The literature 
also reveals that there are differences between general population and active 
populations regarding pain tolerance and pain threshold levels.  However, it has yet to 
be researched if the commonly used pain scales used in the general population are as 
reliable and valid with active populations.  Valid and reliable assessments of pain are 
required for effective pain management.  The use of algometers could give a reliable 
measurement of pain that is quantified.  Additionally, algometers can be used 
repeatedly to observe the progression of pathology or impact of treatment regarding 
pain measurement. To begin integrating algometry into common practices, more 
research needs to be completed to further demonstrate its efficacy and feasibility.  
The purpose of this study was to determine if there were correlations between the 
subjective measurements of commonly used pain scales to objectively measures with 




One group specifically recruited was men and women student collegiate 
athletes that participate in National Collegiate Athletic Association (NCAA) sanctioned 
sports. Other potential participants were recruited through club activity participation 
as well as others whom self-identified as recreational athletes. These participants were 
collectively termed “non-collegiate athletes”.  All participants did not have any 
restrictions from physical activity from their physicians but had some form of joint pain 
currently being experienced and were between the ages of 18-35.  All participants 
were told that the study is voluntary and there were no repercussions for choosing to 
not participate in the study.  Student collegiate athlete participants were specifically 
told that their answers would not have any impact on playing time or status on the 
team.  Potential participants were asked if they would like to participate. If they 
agreed, then they filled out an informed consent form. Afterwards, participants 
completed a general information demographic form which includes age, years 
participating in the present sport/activity, gender, history of injury, sport, existence of 
current pain, pain rating, and injury status.  
Participants then completed the following forms in a randomized order: 
numerical rating scale (NRS), 5-point verbal rating scale (VRS-5), visual analog scale 
(VAS), Mankoski scale, patient-specific functional scale (PSFS), pain catastrophizing 
scale (PCS), and the brief resilience scale (BRS) [see appendix].  The PCS and BRS were 
selected in order to determine if other psychological factors were connected to other 
parts of the data that would influence interpretation.  The purpose of including the 
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PSFS was to determine if the participants had self-reported physical dysfunction with 
specific activities as well as pain.  The randomization occurred by each pain scale being 
numbered one through four (NRS, VDS, VAS-5, Mankoski) and the other survey 
components (PSFS, PCS, BRS) were numbered one through three. An online random 
number generator was used to pick corresponding numbers. Each pain scale was 
alternated with one of the other surveys so there were not two pain scales in a row for 
the participant to complete. 
Once the participant completed all forms, the examiner began the algometric 
measurements for the second portion of the experiment. The algometer data was 
collected using a circuit protocol, as explained by Bisset et al 35.  Subjects were seated 
on an examination table.  The examiner placed the rubber end of the algometer 
(Wagner FPX FDX 25 force gauge) over the body region that was tested. The examiner 
pressed the algometer against the body area and instructed the subject to report 
when the pressure of the algometer device began to feel uncomfortable but not yet 
painful – thus measuring the pressure discomfort threshold (PDT).  Without stopping, 
the examiner continued to apply pressure until the subject stated the pressure was 
painful and so measured the participant’s pain pressure threshold (PPT) level. 
Measurements were taken on both sides of the body at the site the participant had 
reported joint pain as well as three predetermined anatomical locations.  The 
predetermined sites were the erector spinae – 2 cm lateral to the fourth and fifth 
vertebrae junction, the “anatomical snuffbox” on the medial aspect of the joint line of 
the wrist, and the joint space inferior to the medial femoral epicondyle. Three 
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different measurements were taken at each site, rotating to the next site after each 
measurement was taken. If the participant presented with joint pain at a 
predetermined test site, then that site would account for the predetermined site as 
well as the site of joint pain for measurements rather than test the same site twice. In 
such cases then there would be 3 bilateral sites measured rather than 4.  The clinician 
tested the site once and then rotated to the next site and continued until 3 
measurements at all 4 sites were collected.  The peak number measured each time, 
averaged and then the averaged value was used for statistical analysis.  
Data Analysis 
Summary statistics for demographic items were calculated and reported as 
means and standard deviations for continuous variables and frequencies and 
percentages for categorical variables.  Univariate comparisons were made between 
each group (sport level: collegiate athlete versus non-collegiate athlete), gender 
(men versus women), and current injury (yes versus no) using independent t-tests 
based on normality of each variable distribution.  The distribution of data was 
normal from the Shapiro-Wilk test.  Pearson’s correlations (r) were performed to 
determine if a relationship existed amongst any of the dependent variables.  The 
correlations were performed for all subjects as well as for each group.  Correlation 
coefficients were interpreted as: 0.00-0.30=negligible; 0.31-0.50=low positive 
correlation; 0.51-0.70=moderate positive correlation; 0.71-0.90=high positive 
correlation; and 0.91-1.00-very high positive correlation51.  Any negative correlations 
would be interpreted as the inverse of the positive correlation interpretation.  
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Statistical significance was set at p≤0.05.  All analyses were performed on SPSS 
(v26, IBM, Armonk, NY).  
To ensure the consistency of measurement obtained by the examiner, a 
reliability assessment for each of the algometer sites was performed.  A sample of 
seven participants who were not included in the actual study was obtained for this 
purpose.  Using a two-way random design (2,1), intraclass correlation coefficients 
(ICC) were calculated from the two trials of each test site obtained for a single 
examiner.  This same examiner also gathered all of the study data for all trials. 
Intrasession test/retest reliability was calculated.  Once the ICC’s were determined, 
standard error of measurement (SEM) and minimal detectable change (MDC) at the 
90% confidence level were calculated.  An ICC ≥0.75 was interpreted as excellent 
while values between 0.40–0.74 were considered fair to good and <0.40 was 
considered poor52.  Test/re-test intrasession reliability was revealed to be excellent 
(ICC≥0.78) for all testing sites (Table 1). 
A sample size of 62 participants would have 80% power for a low positive 
correlation of r=0.35 between the pain assessments with a two-sided significance 
level of 0.05.  To account for 10% attrition, collection continued until 69 
participants completed the study.   
Results 
The total sample size included 69 participants (Age: 21.3 ± 2.2, 33 men, 36 
women).  The participants averaged 11.5 ± 7.0 hours per week in physical activity. 
Within the men, 18 were NCAA collegiate athletes while 15 were club, recreational, or 
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non-collegiate athletes. Within the women, 14 were NCAA collegiate athletes while 22 
were club, recreational, or non-athletes.   
Table 1: Reliability Table 
 Mean (±SD) ICC SEM MDC Lower CI Upper CI 
R wrist PDT 23.1±8.8 0.93 2.3 5.4 0.6 0.99 
R wrist PPT 29.6±9.5 0.93 2.5 5.8 0.57 0.99 
R wrist PR 2.0±1.1 0.96 0.2 0.5 0.77 0.99 
L wrist PDT 24.7±9.2 0.94 2.2 5.2 0.67 0.99 
L wrist PPT 32.1±10.2 0.92 2.9 6.7 0.51 0.99 
L wrist PR 2.0±1.1 0.99 0.1 0.2 0.98 0.99 
R knee PDT 42.9±16.7 0.83 6.9 16.1 0.01 0.97 
R knee PPT 57.4±20.5 0.78 9.6 22.4 -0.26 0.96 
R knee PR 1.7±1.1 0.96 0.2 0.5 0.78 0.99 
L knee PDT 42.8±20.1 0.94 4.9 11.5 0.65 0.99 
L knee PPT 56.4±22.3 0.9 7.1 16.5 0.4 0.98 
L knee PR 1.6±1.1 0.98 0.2 0.4 0.88 0.99 
R back PDT 37.6±16.0 0.95 3.6 8.3 0.72 0.99 
R back PPT 49.4±16.6 0.8 7.4 17.3 -0.16 0.97 
R back PR 1.6±1.1 0.98 0.2 0.4 0.87 0.99 
L back PDT 43.1±25.7 0.94 6.3 14.7 0.66 0.99 
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  Table 1 (Continued)    
 Mean (±SD) ICC SEM MDC Lower CI Upper CI 
L back PPT 55.8±27.6 0.96 5.5 12.9 0.75 0.99 
L back PR 1.8±1.3 0.98 0.2 0.4 0.91 0.99 
Amongst sport level (collegiate athlete versus non-collegiate athlete), there 
were two significant differences (Table 2).  First, there were significantly higher ratings 
on the NRS for collegiate athletes (collegiate athlete NRS = 4.0 ± 1.9) compared to non-
collegiate athletes (non-collegiate athlete NRS = 2.9 ± 1.7, p = 0.016).  Second, the PSFS 
ratings for collegiate athletes (PSFS = 12.35 ± 6.9, p = 0.035) were significantly lower 
compared to the non-collegiate athletes (PSFS = 15.5 ± 5.2).  There were similar scores 
seen between collegiate athlete and non-collegiate athlete groups regarding BRS and 
PCS.  While not statistically significant, the collegiate athletes consistently tolerated 
more force applied during the algometry measurements than the non-collegiate 
athletes, which is consistent with current literature.   
Within the collegiate athletes’ data, the Mankoski scale was the only pain scale 
that had consistently moderate to high positive correlations to the other pain scales (r 
= 0.511-0.730, p ≤ 0.003).  The VRS-5 was the only pain scale significantly correlated to 
the injured PDT and PPT but it was a low negative correlation (r = -0.374-0.388, p ≤ 
0.042).  The only correlation between pain scales and PCS was VRS-5 had a low positive 
correlation to PCS total score (r = 0.413, p = 0.026).  Within the non-collegiate athletes’ 
group, there was a more consistent moderate to high positive correlations between all 
of the pain scales (r = 0.518-0.820, p ≤ 0.002).  The PCS total as well as rumination and 
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helplessness subcategories had consistently low to moderate positive correlations to 
all of the pain scales (r = 0.425-0.570, p ≤ 0.009).  The PCS helplessness was found to 
have a low negative correlation to PSFS (r = -0.346, p = 0.039).  The only variable 
correlated to the algometry measurements was BRS which had a low positive to both 
injured and non-injured PDT/ PPT values (r = 0.338-0.463, p ≤ 0.041).   
Table 2: Summary Statistics for Collegiate Athlete versus Non-Collegiate Athlete 
  Mean P-value 
NRS Athlete (n=32) 4.0 ± 1.9 0.016 
 Non-Athlete (n=37) 2.9 ± 1.7  
VAS Athlete (n=28) 3.7 ± 2.1 0.168 
 Non-Athlete (n=37) 3.0 ± 1.9  
VRS-5 Athlete (n=30) 1.8 ± 0.8 0.878 
 Non-Athlete (n=36) 1.8 ± 0.7  
Mankoski Athlete (n=31) 3.1 ± 1.9 0.889 
 Non-Athlete (n=35) 3.1 ± 1.5  
PCS Total Athlete (n=32) 15.7 ± 9.7 0.484 
 Non-Athlete (n=37) 14.0 ± 10.0  
PCS Rumination Athlete (n=31) 5.0 ± 3.3 0.851 
 Non-Athlete (n=37) 5.3 ± 4.4  
PCS Magnification Athlete (n=31) 4.0 ± 2.3 0.118 
 Non-Athlete (n=37) 3.1 ± 2.6  
PCS Helplessness Athlete (n=31) 6.4 ± 5.4 0.569 
 Non-Athlete (n=37) 5.7 ± 4.4  
PSFS Total Athlete (n=31) 12.35 ± 6.9 0.035 
 Non-Athlete (n=36) 15.5 ± 5.2  
BRS Total Athlete (n=32) 22.5 ± 4.3 0.813 
 Non-Athlete (n=37) 22.3 ± 4.8  
Avg PDT injured side Athlete (n =32 ) 50.5 ± 30.7 0.397 
 Non-Athlete (n=37) 43.8 ± 34.4  
Avg PPT injured side Athlete (n=32) 63.5 ± 34.7 0.412 
 Non-Athlete (n=37) 56.0 ± 39.7  
Avg PDT non-injured Athlete (n=32) 55.3 ± 29.6 0.159 
 Non-Athlete (n=36) 44.6 ± 31.8  
Avg PPT non-injured Athlete (n=32) 66.8 ± 32.6 0.427 
 Non-Athlete (n=36) 60.0 ± 37.4  
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Table 3: Correlation Statistics for Collegiate Athlete versus Non-Collegiate Athlete 
 












 ** Correlation is significant at the 0.01 level (2-tailed).  
 










** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 
level (2-tailed).  
Table 3 (Continued) 
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There were no significant differences found when the data was sorted by 
gender (Table 4).  Both men and women had similar pain rating ranges (men: 1.7-3.8, 
women: 1.9-3.3) but men tolerated higher amounts of force (men: 50.2-68.8N, 
women: 43.9-57.9N), congruent with current literature. While men and women had 
similar PCS values with no statistical significance, men consistently had slightly 
elevated levels with exception to PCS helplessness.  Within the men’s data, all of the 
pain scales had low to high positive correlations to each other (r = 0.492-0.784, p ≤ 
0.005).  The PCS total had low positive correlations to all the pain scales, except 
Mankoski (r = 0.352-0.411, p ≤ 0.048).  The VRS-5 was the only pain scale with low 
negative correlations to the algometry measurements (r = -0.374-0.383, p ≤ 0.038).   
Within the women’s data, all of the pain scales had low to moderate positive 
correlations (r = 0.437-0.69, p ≤ 0.01).  The PCS total and helplessness scores had 
consistent low positive correlations to all of the pain scales (r = 0.351-0.464, p ≤ 0.045).  
BRS had low positive correlation to the average PDT and PPT on the injured side (r = 









Table 4: Summary Statistics by Gender 
  Mean P-value 
NRS Female (n=36) 3.1 ± 1.9 0.118 
 Male (n=33) 3.8 ± 1.8  
VAS Female (n=33) 3.25 ± 2.0 0.943 
 Male (n=32) 3.3 ± 2.0  
VRS-5 Female (n=35) 1.9 ± 0.7 0.253 
 Male (n=31) 1.7 ± 0.8  
Mankoski Female (n=35) 3.2 ± 1.5 0.566 
 Male (n=31) 3.0 ± 2.0  
PCS Total Female (n=36) 14.5 ± 9.2 0.844 
 Male (n=33) 15.0 ± 10.7  
PCS Rumination Female (n=35) 5.0 ± 4.0 0.679 
 Male (n=33) 5.4 ± 3.85  
PCS Magnification Female (n=35) 3.3 ± 2.4 0.440 
 Male (n=33) 3.8 ± 2.6  
PCS Helplessness Female (n=35) 6.1 ± 4.1 0.903 
 Male (n=33) 6.0 ± 5.7  
PSFS Total Female (n=35) 13.8 ± 14.3 0.722 
 Male (n=32) 14.3 ± 5.9  
BRS Total Female (n=36) 22.7 ± 4.4 0.565 
 Male (n=33) 22.0 ± 4.7  
Avg PDT injured side Female (n=36) 43.9 ± 34.0 0.429 
 Male (n=33) 50.2 ± 31.2  
Avg PPT injured side Female (n=36) 55.05 ± 38.6 0.304 
 Male (n=33) 64.4 ± 35.9  
Avg PDT non-injured Female (n=35) 45.9 ± 30.7 0.315 
 Male (n=33) 53.5 ± 31.3  
Avg PPT non-injured Female (n=35) 57.9 ± 35.85 0.201 






Table 5: Correlation Statistics for Gender 
 
Continued on next page 
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Table 5 (Continued) 
 
** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 
level (2-tailed).  
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The data was also sorted and analyzed by current injury status.  Participants 
who identified as injured had a higher NRS pain rating score (4.2 ± 1.8) compared to 
participants who were not injured (2.9 ± 1.8, p = 0.005).  Additionally, the same results 
were found regarding the VAS (injured = 4.1 ± 2.1, p = 0.006, non-injured = 2.7 ±1.76) 
and the Mankoski scale (injured = 4.12 ± 2.1, p = 0.045, non-injured = 2.7 ± 1.76).  
Those who were injured also reported lower values on the PSFS compared to non-
injured (injured: 12.5±6.1, non-injured: 15.05±6.1).  The injured group also consistently 
tolerated a similar amount of force as the non-injured group on both the injured and 
non-injured sides (injured group on injured side PDT: 46.8±33N, uninjured group on 
injured side PDT: 47.0±32.8N, injured group on injured side PPT: 59.6±37.5N, uninjured 
group on injured side PPT: 59.4±37.7N, injured group on uninjured side PDT: 
52.7±32.2N, uninjured group on uninjured side PDT: 47.8±30.5N, injured group on 
uninjured side PPT: 66.7±35.6N, uninjured group on uninjured side PPT: 61.1±35.1N) 
(Table 6).   
Within the injured group’s data, the pain scales had low to high positive 
correlations to each other (r = 0.454-0.833, p ≤ 0.023).  Only the VRS-5 scale had a 
connection to the PCS total and PCS helplessness scores with low to moderate positive 
correlations (r = 0.461-0.555, p ≤ 0.021).  Additionally, the VRS-5 was the only pain 
scale connected to algometry measurements with a low to moderate negative 
correlation (r = -0.471-0.514, p ≤ 0.023).  Within the non-injured group, all of the pain 
scales had low to moderate positive correlations to each other (r = 0.369-0.604, p ≤ 
0.019).  The PCS total and rumination scores had low positive correlations to all of the 
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pain scales (r = 0.336-0.49, p ≤ 0.034).  The PCS helplessness subcategory had low 
positive correlations to all pain scales, except Mankoski (r = 0.329-0.487, p ≤ 0.036).  
The BRS had low negative correlations to VAS and PCS rumination (r = -0.756-0.382, p 
≤ 0.024).  The BRS scores were also correlated to the average PDT and PPT values on 
both injured and uninjured sides with low positive correlations (r = 0.332-0.378, p ≤ 
0.03)(Table 7).   
 
Table 6: Summary Statistics by Current Injury 
  Mean P-value 
NRS No Injury (n=43) 2.9 ± 1.8 0.005 
 Injury (n=26) 4.2 ± 1.8  
VAS No Injury (n=40) 2.7 ± 1.8 0.006 
 Injury (n=25) 4.1 ± 2.1  
VRS-5 No Injury (n=41) 1.7 ± 0.6 0.110 
 Injury (n=25) 2.0 ± 0.9  
Mankoski No Injury (n=40) 2.8 ± 1.5 0.045 
 Injury (n=26) 3.6 ± 1.9  
PCS Total No Injury (n=43) 13.9 ± 8.9 0.337 
 Injury (n=26) 16.2 ± 11.3  
PCS Rumination No Injury (n=43) 4.7 ± 3.5 0.175 
 Injury (n=25) 6.0 ± 4.3  
PCS Magnification No Injury (n=43) 3.65 ± 2.6 0.558 
 Injury (n=25) 3.3 ± 2.4  
PCS Helplessness No Injury (n=43) 5.6 ± 3.8 0.404 
 Injury (n=25) 6.8 ± 6.3  
PSFS Total No Injury (n=41) 15.05 ± 6.1 0.100 
 Injury (n=26) 12.5 ± 6.1  
BRS Total No Injury (n=43) 22.7 ± 4.8 0.441 
 Injury (n=26) 21.85 ± 4.0  
Avg PDT injured side No Injury (n=43) 47.0 ± 32.8 0.983 
 Injury (n=26) 46.8 ± 33.0  
Avg PPT injured side No Injury (n=43) 59.4 ± 37.7 0.981 
 Injury (n=26) 59.6 ± 37.5  
Avg PDT non-injured No Injury (n=43) 47.8 ± 30.5 0.531 
 Injury (n=25) 52.7 ± 32.2  
Avg PPT non-injured No Injury (n=43) 61.1 ± 35.1 0.529 
 Injury (n=25) 66.7 ± 35.6  
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** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 
level (2-tailed). 
Table 7 (Continued) 
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Discussion 
From the results altogether, all pain scales had some form of positive 
correlation, regardless of how data was sorted for interpretation.  Therefore, all of the 
pain scales consistently and accurately assess pain intensity in and can be used in the 
clinical setting.  For consistent measurements and accurate assessment, once a pain 
scale is selected it should be consistently used.  While the subjective pain scales were 
moderate to high correlations to each other and separately the algometric 
measurements were highly correlated to each other, there were few correlations 
connecting the subjective pain scales to the algometry measurements – only VRS-5 in 
collegiate athletes, men, and injured subgroups.  Thus, only the first hypothesis of the 
study is partly accepted – pain ratings from subjective pain scales were consistently 
significantly correlated to one another but did not consistently correlate to the 
algometry measurements.  From these results, algometry measurements cannot be 
used to form a quantified value for pain level experienced – especially when the pain is 
not being directly caused by an external stimulus.  One may still be able to use 
algometry measurements as a form of measuring progression of specific treatments 
due to repeated measures using algometry with pathologies that include point specific 
tenderness, as seen with Kregel et al and van Wilgen et al 39,43.  
When reviewing the results between collegiate athletes and non-collegiate 
athletes, collegiate athletes’ pain ratings on the NRS were consistently higher while 
also rating themselves as less functional than non-collegiate athletes.  One potential 
reason why collegiate athletes rated themselves as less functional than non-collegiate 
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athletes were that the activities they chose when they completed the PSFS were more 
difficult than those chosen by non-collegiate athletes. For example, collegiate athletes 
with shoulder pain often provided task examples on the PSFS such as ‘throwing a 
football’ while non-collegiate athlete participants with shoulder pain included activities 
that were often categorized under activities of daily living i.e.  ‘putting away dishes’.  
However, throwing a football is a more complex task that often requires more effort to 
be exerted than putting away dishes.  Another potential explanation surfaces with the 
research completed by Simon and Docherty (2014)53, who found that collegiate 
athletes had a higher number of injuries as well as more severe injuries than non-
collegiate athletes which led to long term limitations of exercise, activities of daily life, 
and overall decrease in health-related quality of life.  Based on the differences seen 
between collegiate athletes and non-collegiate athletes in the current study, there is 
potential that the limitations the former collegiate athletes were experiencing per 
Simon and Docherty began to occur prior to terminating their athletic careers rather 
than after athletic participation ceased. 
While not statistically significant, collegiate athletes consistently tolerated 
higher forces applied within the algometry measurements, as seen consistently with 
the current literature 34,46,47.  Thus, the second hypothesis of the study is accepted by 
athletes having higher pain thresholds and tolerances.  There are several different 
theories in the current literature as to why athletes have higher pain thresholds and 
tolerances than non-athletes.  It is commonly agreed upon that during and directly 
following exercise, pain modulation is seen via acute exercise induced analgesia from 
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endogenous opioid systems within the body13,33,46.  It is unknown for people who 
exercise on a regular basis if there are long term adaptations, regarding their pain 
tolerance and their pain modulation ability.  Several studies found that athletes had 
higher pain tolerances and/or enhanced conditioned pain modulation abilities 
compared to sedentary or active controls29,33,46,47,54.  There were also studies that 
found no differences between athletes and sedentary or active controls regarding pain 
tolerances and conditioned pain modulation29.  Additionally, the mechanisms of how 
athletes may have higher pain tolerances and augmented pain modulation abilities is 
unclear13,29,33,46,55.  The most common theory is that exercise causes the release of 
generalized endogenous pain modulatory mechanisms, potentially via hypothalamic 
pituitary adrenal axis and baroreflex-mediated analgesia29,46,54.  Furthering that theory, 
Flood suggested that repeated bouts of exercise causes a strengthening of the neural 
pathway of pain modulation to explain why athletes have higher pain modulation than 
sedentary46.  The concept is similar to how people sweat more and sooner when they 
adapt to warmer environments.   Deroche found that athletes are better at mentally 
ignoring pain and the more athletes ignore pain during activity the higher their pain 
tolerance goes and it improves their pain modulation ability47.  A similar theory 
surfaced within the systematic review by Tesarz, that successful athletes that compete 
at a higher level do so by athletic selection process, where the athletes who can 
naturally tolerate more pain tend to be more successful in higher level competition 
athletics29.  It is difficult to ascertain why collegiate student-athletes have higher pain 
thresholds and tolerances due to this study’s experimental design since it was not a 
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priority of the investigation but it is possible that the increased algometric thresholds 
tolerated by the collegiate athletes could be due to enhanced pain modulation.  
Pain catastrophizing had low to moderate correlations to pain scales more 
consistently in the non-collegiate athlete group thus demonstrating how pain 
catastrophizing does influence pain tolerances, as also seen in current literature 34,46.  
Similar results have also been seen in other studies like Sullivan et al (2000), where 
male collegiate athletes were found to have the lowest PCS score, followed by female 
collegiate athletes then sedentary males and sedentary females, respectively34.  
Comparing the findings from this study to Sullivan et al (2000), that total values from 
the PCS are very close regarding the collegiate athletes but differ regarding non-
collegiate athletes (Current study: collegiate athletes 15.7±9.7, non-collegiate athletes 
14.0±10.0 and Sullivan: collegiate athletes 17.1±7.3, sedentary 20.0±9.1).  The 
differences between the values of non-collegiate athletes and sedentary between the 
two studies may be due to differences in population composition because our non-
collegiate athlete subgroup included club athletes, recreational athletes and active 
participants.  Pain catastrophizing is present in both populations as seen with similar 
scores between both groups, but collegiate athletes tolerate or have found coping 
mechanisms to deal with pain catastrophizing more than non-collegiate athletes, 
which may explain why there are more consistent correlations between pain scales 
and PCS in non-collegiate athlete populations.  In another study that examined 
demolition derby participants, they found that there was much lower prevalence of 
neck pain from whiplash in the demolition derby participants compared to the amount 
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of whiplash patients from motor vehicle collision accidents 56.  A potential theory, 
called the price of doing business, demonstrates the derby demolition participants 
expected and had accepted the risk and pain associated with their activity.  In other 
literature, it has been seen that pain acceptance specifically decreases pain levels57-59.  
These differences in mentality seen in the demolition derby participants may be the 
reason why they have less severe symptoms that resolve sooner than individuals who 
are in motor vehicle collisions. 
There were no significant differences between gender seen in this study, which 
continues to demonstrate the conflicting results found in current literature 34,60-62.  
While it was not statistically significant, men tolerated more force (N) applied during 
algometric measurements consistently compared to women in this study, which is 
congruent with current literature41,62.  Additionally, men had higher but not 
statistically different ratings on the pain catastrophizing scales compared to women, 
apart from PCS helplessness subcategory rating.  However, pain scales were more 
consistently correlated to the PCS total and helplessness scores with women.  
Therefore, even though men had higher ratings of pain catastrophizing, it did not 
affect their subjective pain ratings/ pain scale values.  Women’s pain catastrophizing 
scores were connected to their subject pain ratings, even though they had lower pain 
catastrophizing scores than men.  This may demonstrate that women are more 
affected by pain catastrophizing than men.  However, there is not a clear consensus in 
current literature regarding gender differences with pain catastrophizing.  From 
Sullivan et al (1995), when the PCS scale was created and validated, women were 
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found to have higher PCS results than men10.  While Sullivan et al. (1995), contradicts 
the results from our study, Sullivan et al (2000) and Sullivan et al (2002) found similar 
PCS values to our study and resulted in no significant differences between 
gender10,34,63.  Additionally, studies completed by Otto, Emery, and Cote (2019) and 
Schrooten, Karsdorp, and Vlaeyen (2012) did not find significant differences between 
gender and pain catastrophizing – all using Sullivan (1995) PCS 10,61,62.  There were no 
significant correlations between any of the PCS scores and any of the algometry 
measurements.  These results demonstrate that pain catastrophizing influences 
subjective pain ratings when rating pain in general rather than when rating pain 
concurrently with nociceptive stimulus applied.  In another study conducted by Halls 
and Davies where collegiate athletes were compared to non-collegiate athletes, they 
found no significant differences in pain perception and affect of pain60.  However, 
there was statistically significant difference between the collegiate athletes and non-
athletes60.  Female non-athletes having the highest pain rating and were the most 
affected by the painful procedure 60.  It is likely then athletic participation is a 
confounding variable when examining pain catastrophizing and pain response in 
female subjects.  With inconsistent findings in literature, research needs to continue to 
investigate if there is a relationship between gender, pain catastrophizing, subjective 
pain ratings and algometric measurements. 
There is a difference between being in pain and being injured. When subjects 
identified themselves as injured, they had higher pain ratings (PR) compared to non-
injured with NRS, VAS, and Mankoski scale.  However, there was not a similar decrease 
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in PDT, PPT, or increase PR averages in injured people.  When a person mentally shifts 
from being in pain to being injured, there is a change in their status.  This mentality 
change may explain why the injured subgroup has higher pain ratings on subjective 
measures that were incongruent with objective measures.  Within the injured group, 
only the VRS-5 was connected to PCS total, PCS helplessness, and algometry 
measurements.  These correlations may be seen due to the VRS-5 scale being relatively 
general compared to the other pain scales, being based on a 5-point scale rather than 
a 10-point scale.  There were more consistent correlations between all of the pain 
scales and the PCS total and rumination scores within the non-injured group.  The 
study by Deroche et al (2011) suggests that repeated exposure to painful stimulus 
enables people to ignore pain better and so increases pain tolerance47.  Thus, 
demonstrating how people who are injured develop pain tolerances and positive 
coping techniques when in pain, due to necessity.  Another factor may be conditioned 
pain modulation which is the reduction of intensity from a painful stimulus when a 
second stimulus is applied.  These specific participants were already in pain due to an 
injury and so when the algometry measurements were taken, a secondary painful 
stimulus was applied64.  Additionally, when the data was reviewed, 69% of the injured 
group were collegiate athletes.  This could explain why there was not a significant 
difference in the algometry measurements as one would expect. 
 With this study there are some specific limitations.  The sample size was of 
college students and so is a sample of convenience since the study was hosted as at a 
university.  Working with college students, there is the potential that participants did 
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not fully understand the questions while completing each of the questionnaires. 
However, all participants were reminded that questions could be asked and the 
investigators were present at all data collection sessions. As well, some participants 
may have not had joint pain but have pain manifest in what they believe as the joint 
from an underlying cause, like muscle imbalance.  Participants also could have been 
confused or misinterpreted the instructions during the algometry measurements and 
thus potentially skewing the data.  Additionally, there is a limited amount of different 
sports available to sample and so data couldn’t be compared regarding level of contact 
within the collegiate athletes’ subgroup.  Since there was only one primary 
investigator, there could not be any blindness between investigator and participants to 
blind from collegiate athlete status and potential injury status.   
With the results found from this study, several differing branches of future 
research surfaces.  A larger sample sized focused on different sports with varying 
amount of contact to determine if increased exposure to high contact positions 
influences athletes to have higher pain thresholds and tolerances could determine if 
pain tolerance is innate or something developmentally based.  In current research, 
increased ability in pain modulation has been seen in athletes34,46, but especially 
marathon runners54,65 and so further research comparing contact based and non-
contact-based sports should occur.  As previous evidence has suggested, a person’s 
mental approach to pain and other mental health factors has a significant influence on 
pain perception 10,34,46,57,61.  Furthermore, a longitudinal study of athletes while they 
are in their competitive season or off while monitoring their stress could show how 
43 
significant an individual’s mentality is to pain ratings.  Additionally, a longitudinal study 
that monitors pain thresholds and tolerances in the four years of collegiate 
participation to investigate if pain threshold and tolerances increase over years of 
participating in college athletics would yield interesting results.  Another potential 
variable that was not investigated within this study is BMI.  In some research, an 
increased BMI level, with a mean of 31.0±7.2 kg/m2, is correlated with higher pain 
ratings and even disability ratings 58.  How BMI levels could influence pain ratings in 
athletes is unknown and should be investigated further.  Previous literature has not 
consistently identified gender differences between pain perception; however, some 
studies have found that men report lower pain ratings than women 34,41.  While this 
study’s results demonstrate that there are no differences between biological sex, it is a 




From the results of the data collected, each pain scale used within the study 
was found to be correlated to each other consistently.  Therefore, the NRS, VRS, VAS, 
and Mankoski scale all measure pain intensity accurately and reliably.  Any four of the 
pain scales used in this study could be used in a clinical setting to accurately and 
reliable measure pain intensity with patients – including the athletic population.  
However, once a pain scale is chosen to be used, it should be used consistently.  There 
was no statistical difference between gender regarding PDT, PPT, or pain rating.  Both 
genders are influenced by pain catastrophizing which has been a significant influence 
in other studies in the literature but needs to be continued to be researched 34,57,61,66-
69.  Additionally, being in pain and identifying as injured may cause a difference in pain 
ratings.  With increased levels of pain ratings and pain catastrophizing in non-injured 
and non-collegiate athletes may demonstrate that the first major injury causes 
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Appendix A: Numerical Rating Scale (NRS) 
 
The 11-point Box Scale (BS-11) 
 If a zero (0) means “no pain” and a ten (10) means “pain as bad as it could be”, 
on this scale of 0 to 10, what is your level of pain? Put an “X” through the number. 
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Appendix B: Visual Analogue Scale 
Please mark where your pain is on the line below 
 
______________________________________________________ 
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Appendix C: Verbal Rating Score (VRS-5) 
The 5-point Verbal Rating Scale (VRS-5) 
Please indicate which word best describes your pain level. 
 (     ) Mild 
 (     ) Discomforting 
 (     ) Distressing 
 (     ) Horrible 
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Appendix D: Mankoski Pain Scale 
Mankoski Pain Scale – A Numeric Pain Intensity Scale 
Please circle the number that best describes your pain level. 
0 No pain No medication needed 
1 Very minor annoyance – occasional minor 
twinges 
No medication needed 
2 Minor annoyance – occasional strong twinges No medication needed 
3 Annoying enough to be distracting Mild painkillers are 
effective (Aspirin, 
Ibuprofen, Tylenol) 
4 Can be ignored if you are really involved in 
your work, but still distracting. 
Mild painkillers relieve 
pain for 3-4 hours 
5 Can’t be ignored for more than 30 minutes. Mild painkillers reduce 
pain for 3-4 hours 
6 Can’t be ignored for any length of time, but 
you can still go to work and participate in 
social activities. 
Stronger painkillers 
(Codeine, Vicodin) reduce 
pain for 3-4 hours 
7 Makes it difficult to concentrate, interferes 
with sleep. You can still function with effort. 
Stronger painkillers are 
only partially effective. 
Strongest painkillers 
relieve pain (Oxycontin, 
Morphine) 
8 Physical activity severely limited. You can 
read and converse with effort, Nausea and 
dizziness set in as factors of pain. 
Stronger painkillers are 
minimally effective. 
Strongest painkillers 
reduce pain for 3-4 hours. 
9 Unable to speak. Crying out or moaning 
uncontrollably near delirium. 
Strongest painkillers are 
only partially effective. 
10 Unconscious. Pain makes you pass out. Strongest painkillers are 
only partially effective. 
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Appendix E: Pain Catastrophizing Scale 
When I’m in pain… (Circle the best answer for each statement) 
 Not at all Mildly Moderately Severely All the time 
I worry all the time about 
whether the pain will end 
 
1 2 3 4 5 
I feel I can’t go on 
 1 2 3 4 5 
It’s terrible and I think it’s 
never going to get any 
better 
 
1 2 3 4 5 
It’s awful and I feel that it 
overwhelms me 
 
1 2 3 4 5 
I feel I can’t stand it 
anymore 
 
1 2 3 4 5 
I become afraid that the 
pain will get worse 
 
1 2 3 4 5 
I keep thinking of other 
painful events 
 
1 2 3 4 5 
I anxiously want the pain to 
go away 
 
1 2 3 4 5 
I can’t seem to keep it out of 
my mind 
 
1 2 3 4 5 
I keep thinking about how 
much it hurts 
 
1 2 3 4 5 
I keep thinking about how 
badly I want the pain to stop 
 
1 2 3 4 5 
There’s nothing I can do to 
reduce the intensity of the 
pain 
 
1 2 3 4 5 
I wonder whether 
something serious may 
happen 
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Appendix F: Patient Specific Functionality Scale (PSFS) 
 
I am going to ask you to identify up to 3 important activities that you are unable to do 
or are having difficulty with as a result of your ___________________problem.  Today, 
are there any activities that you are unable to do or are having difficulty with because 
of your _______________problem? 
 
Score each activity you are unable to do or are having difficulty with that would fall 
into each category 
 
Scoring Scale (Select 1 number only for each activity listed above) 
 
0 1 2 3 4 5 6 7 8 9 10 
Unable to        Able to perform 
Perform        activity at the same 
Activity        level as before 




 0 1 2 3 4 5 6 7 8 9 10 
 
 0 1 2 3 4 5 6 7 8 9 10 
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Appendix G: Brief Resilience Scale (BRS) 
Brief Resilience Scale 
Please indicate which box response is most accurate to the accompanying statement. 
  Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
BRS 1 I tend to bounce back 










BRS 2 I have a hard time 












BRS 3 It does not take me 
long to recover from 











BRS 4 It is hard for me to 













BRS 5 I usually come 
through difficult 












BRS 6 I tend to take a long 
time to get over 
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Appendix H: Algometry Measurements 
Please hand your packet back to the researcher. 
Thank you for your participation! 
 
Anatomical Snuffbox (right) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
Anatomical Snuffbox (left) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
Medial Knee Joint Space (right) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
Medial Knee Joint Space (left) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 





Erector Spinae (right) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
Erector Spinae (left) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
Joint Pain Site: ______________________________ (right) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
Joint Pain Site: _______________________________(left) 
 PDT 1: ______  PPT 1: ______  Pain Rating (0-10): _______ 
 PDT 2: ______  PPT 2: ______  Pain Rating (0-10): _______ 
 PDT 3: ______  PPT 3: ______  Pain Rating (0-10): _______ 
 
